You are on page 1of 1

Federal Register / Vol. 67, No.

217 / Friday, November 8, 2002 / Notices 68149

a government I.D. will need to show a Name of Committee: National Institute on Date: December 2, 2002.
photo I.D. and sign-in at the security Aging Special Emphasis Panel, Human Time: 1:30 p.m. to 3:30 p.m.
desk upon entering the building. Genetics. Agenda: To review and evaluate grant
Date: November 18–19, 2002. applications.
Information is also available on the Time: 7 p.m. to 5 p.m. Place: One Democracy Plaza, 6701
Institute’s/Center’s home page: Agenda: To review and evaluate grant Democracy Blvd., Suite 800, Bethesda, MD
deainfo.nci.nih.gov/advisory/ncab.htm, applications. 20892, (Telephone Conference Call).
where an agenda and any additional Place: The Iberville Suites—New Orleans, Contact Person: Tracy A Shahan, Ph.D.,
information for the meeting will be 910 Iberville Street, New Orleans, LA 70112. Scientific Review Administrator, National
Contact Person: Alicja L. Markowska, Institute of Arthritis and Musculoskeletal and
posted when available.
Ph.D., DSC, Scientific Review Office, Skin Diseases, 6701 Democracy Plaza,
(Catalogue of Federal Domestic Assistance Gateway Building/Suite 2C212, 7201 Bethesda, MD 20892, (301) 594–4952.
Program Nos. 93.392, Cancer Construction; Wisconsin Avenue, Bethesda, MD 20817.
(Catalogue of Federal Domestic Assistance
93.393, Cancer Cause and Prevention This notice is being published less than 15
Program Nos. 93.846, Arthritis,
Research; 93.394, Cancer Detection and days prior to the meeting due to the timing
Musculoskeletal and Skin Diseases Research,
Diagnosis Research; 93.395, Cancer limitations imposed by the review and
National Institutes of Health, HHS)
Treatment Research; 93.396, Cancer Biology funding cycle.
Dated: November 4, 2002.
Research; 93.397, Cancer Centers Support; Name of Committee: National Institute on
93.398, Cancer Research Manpower; 93.399, Aging Special Emphasis Panel, Intervention LaVerne Y. Stringfield,
Cancer Control, National Institutes of Health, Panel. Director, Office of Federal Advisory
HHS) Date: November 21, 2002. Committee Policy.
Dated: November 1, 2002. Time: 8 a.m. to 3:30 p.m. [FR Doc. 02–28528 Filed 11–7–02; 8:45 am]
Agenda: To review and evaluate grant
LaVerne Y. Stringfield, BILLING CODE 4140–01–M
applications.
Director, Office of Federal Advisory Place: Gateway Building, 7201 Wisconsin
Committee Policy. Avenue/Suite 2C212, Bethesda, MD 20814.
Contact Person: Arthur D. Schaerdel, DVM,
DEPARTMENT OF HEALTH AND
[FR Doc. 02–28534 Filed 11–7–02; 8:45 am]
The Bethesda Gateway Building, 7201 HUMAN SERVICES
BILLING CODE 4140–01–M
Wisconsin Avenue/Suite 2C212, Bethesda,
MD 20892, (301) 496–9666. National Institutes of Health
DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance National Institutes on Drug Abuse;
HUMAN SERVICES Program Nos. 93.866, Aging Research, Notice of Closed Meetings
National Institutes of Health, HHS)
National Institutes of Health Dated: November 4, 2002. Pursuant to section 10(d) of the
Anna Snouffer, Federal Advisory Committee Act, as
National Institute on Aging; Notice of Deputy Director, Office of Federal Advisory amended (5 U.S.C. Appendix 2), notice
Closed Meetings Committee Policy. is hereby given of the following
[FR Doc. 02–28527 Filed 11–7–02; 8:45 am] meetings.
Pursuant to section 10(d) of the The meetings will be closed to the
BILLING CODE 4140–01–M
Federal Advisory Committee Act, as public in accordance with the
amended (5 U.S.C. Appendix 2), notice provisions set forth in sections
is hereby given of the following DEPARTMENT OF HEALTH AND 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
meetings. HUMAN SERVICES as amended. The grant applications and
The meetings will be closed to the the discussions could disclose
public in accordance with the National Institutes of Health confidential trade secrets or commercial
provisions set forth in sections property such as patentable material,
552b(c)(4) and 552(c)(6), Title 5 U.S.C., National Institute of Arthritis and and personal information concerning
as amended. The grant applications and Musculoskeletal and Skin Diseases; individuals associated with the grant
the discussions could disclose Notice of Closed Meeting applications, the disclosure of which
confidential trade secrets or commercial Pursuant to section 10(d) of the would constitute a clearly unwarranted
property such as patentable material, Federal Advisory Committee Act, as invasion of personal privacy.
and personal information concerning amended (5 U.S.C. Appendix 2), notice Name of Committee: National Institute on
individuals associated with the grant is hereby given of the following Drug Abuse Special Emphasis Panel, Program
applications, the disclosure of which meeting. Project.
would constitute a clearly unwarranted The meeting will be closed to the Date: November 20, 2002.
Time: 10 am to 2 pm.
invasion of personal privacy. public in accordance with the Agenda: To review and evaluate grant
Name of Committee: National Institute on provisions set forth in sections applications.
Aging Special Emphasis Panel, T32’s. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: 6001 Executive Boulevard, Suite
Date: November 12–14, 2002. as amended. The grant applications and 3158, Bethesda, MD 20892–9547 (Telephone
Time: 7 p.m. to 5 p.m. the discussions could disclose Conference Call).
Agenda: To review and evaluate grant confidential trade secrets or commercial Contact Person: Khursheed Asghar, Ph.D.,
applications. property such as patentable material, Chief, Basic Sciences Review Branch, Office
Place: Chevy Chase Holiday Inn, 5520 and personal information concerning of Extramural Affairs, National Institute on
Wisconsin Ave., Chevy Chase, MD 20815. individuals associated with the grant Drug Abuse, National Institutes of Health,
Contact Person: Jeffrey M. Chernak, Ph.D., DHHS, 6001 Executive Boulevard, Room
applications, the disclosure of which 3158, MSC 9547, Bethesda, MD 20892–9547,
The Bethesda Gateway Building, 7201
would constitute a clearly unwarranted (301) 443–2620.
Wisconsin Avenue/Suite 2C212, Bethesda,
MD 20892, (301) 496–9666. invasion of personal privacy. Name of Committee: National Institute on
This notice is being published less than 15 Name of Committee: National Institute of Drug Abuse Special Emphasis Panel,
days prior to the meeting due to the timing Arthritis and Musculoskeletal and Skin Minority Institutions’ Drug Abuse Research
limitations imposed by the review and Diseases Special Emphasis Panel, Gordon Development Program (MIDARP).
funding cycle. Conference Review. Date: December 5, 2002.

VerDate 0ct<31>2002 17:16 Nov 07, 2002 Jkt 200001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1